These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thermodynamic and computational studies on the binding of p53-derived peptides and peptidomimetic inhibitors to HDM2. Grässlin A; Amoreira C; Baldridge KK; Robinson JA Chembiochem; 2009 May; 10(8):1360-8. PubMed ID: 19408261 [TBL] [Abstract][Full Text] [Related]
3. hDM2 protein-binding peptides screened from stapled α-helical peptide phage display libraries with different types of staple linkers. Anananuchatkul T; Tsutsumi H; Miki T; Mihara H Bioorg Med Chem Lett; 2020 Dec; 30(23):127605. PubMed ID: 33038548 [TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the p53/hdm2 protein-protein interaction-path to the clinic. Carry JC; Garcia-Echeverria C Bioorg Med Chem Lett; 2013 May; 23(9):2480-5. PubMed ID: 23541651 [TBL] [Abstract][Full Text] [Related]
5. d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions. Li X; Liu C; Chen S; Hu H; Su J; Zou Y Bioorg Med Chem Lett; 2017 Oct; 27(20):4678-4681. PubMed ID: 28916339 [TBL] [Abstract][Full Text] [Related]
6. Probing the structural requirements of peptoids that inhibit HDM2-p53 interactions. Hara T; Durell SR; Myers MC; Appella DH J Am Chem Soc; 2006 Feb; 128(6):1995-2004. PubMed ID: 16464101 [TBL] [Abstract][Full Text] [Related]
7. A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for the Design of Inhibitors of Intracellular Protein-Protein Interactions by Epitope and Arginine Grafting. Fujiwara D; Kitada H; Oguri M; Nishihara T; Michigami M; Shiraishi K; Yuba E; Nakase I; Im H; Cho S; Joung JY; Kodama S; Kono K; Ham S; Fujii I Angew Chem Int Ed Engl; 2016 Aug; 55(36):10612-5. PubMed ID: 27467415 [TBL] [Abstract][Full Text] [Related]
8. The fluorescent two-hybrid assay to screen for protein-protein interaction inhibitors in live cells: targeting the interaction of p53 with Mdm2 and Mdm4. Yurlova L; Derks M; Buchfellner A; Hickson I; Janssen M; Morrison D; Stansfield I; Brown CJ; Ghadessy FJ; Lane DP; Rothbauer U; Zolghadr K; Krausz E J Biomol Screen; 2014 Apr; 19(4):516-25. PubMed ID: 24476585 [TBL] [Abstract][Full Text] [Related]
9. Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions. Shi Y; Sang P; Lu J; Higbee P; Chen L; Yang L; Odom T; Daughdrill G; Chen J; Cai J J Med Chem; 2020 Nov; 63(21):13187-13196. PubMed ID: 33140956 [TBL] [Abstract][Full Text] [Related]
11. Effect of linker on the binding free energy of stapled p53/HDM2 complex. Im H; Ham S PLoS One; 2020; 15(4):e0232613. PubMed ID: 32353067 [TBL] [Abstract][Full Text] [Related]
12. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators. Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184 [TBL] [Abstract][Full Text] [Related]
13. Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating Peptide. Dougherty PG; Wen J; Pan X; Koley A; Ren JG; Sahni A; Basu R; Salim H; Appiah Kubi G; Qian Z; Pei D J Med Chem; 2019 Nov; 62(22):10098-10107. PubMed ID: 31657556 [TBL] [Abstract][Full Text] [Related]
14. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99. Lee XA; Verma C; Sim AYL Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639 [TBL] [Abstract][Full Text] [Related]
15. A re-examination of the MDM2/p53 interaction leads to revised design criteria for novel inhibitors. Vasilevich NI; Afanasyev II; Kovalskiy DA; Genis DV; Kochubey VS Chem Biol Drug Des; 2014 Nov; 84(5):585-92. PubMed ID: 24797588 [TBL] [Abstract][Full Text] [Related]
16. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy. Shin JS; Ha JH; Chi SW Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622 [TBL] [Abstract][Full Text] [Related]
17. Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres. Gonzalez AZ; Li Z; Beck HP; Canon J; Chen A; Chow D; Duquette J; Eksterowicz J; Fox BM; Fu J; Huang X; Houze J; Jin L; Li Y; Ling Y; Lo MC; Long AM; McGee LR; McIntosh J; Oliner JD; Osgood T; Rew Y; Saiki AY; Shaffer P; Wortman S; Yakowec P; Yan X; Ye Q; Yu D; Zhao X; Zhou J; Olson SH; Sun D; Medina JC J Med Chem; 2014 Apr; 57(7):2963-88. PubMed ID: 24601644 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins. Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548 [TBL] [Abstract][Full Text] [Related]
19. Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction. Cummings MD; Schubert C; Parks DJ; Calvo RR; LaFrance LV; Lattanze J; Milkiewicz KL; Lu T Chem Biol Drug Des; 2006 Mar; 67(3):201-5. PubMed ID: 16611213 [TBL] [Abstract][Full Text] [Related]
20. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors. Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]